MCY vs TECH · P/E 6.7, rev $5.48B vs P/E 65, rev $1.22B
Mercury General Corporation (MCY) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Mercury General Corporation (MCY) is a insurance - property & casualty company listed on NYSE.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported MCY revenue for 2024-12-31 was $5.48B. Net income was $468.0M. Revenue was up 18.3% from 2023-12-31 to 2024-12-31. MCY currently screens at market cap $5.62B and trailing P/E 6.7.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
MCY currently screens at market cap $5.62B and trailing P/E 6.7. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the MCY and TECH stock pages for the full models.
Not investment advice.